Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Antifungal Creams, Moisturizing Lotions, Antibacterial Creams, Others |
| End-User Segment | Hospitals, Clinics, Home Care, Others |
| Distribution Channel Segment | Online, Offline |
|---|---|
| Regions & Countries |
|
The rising prevalence of diabetes globally is increasing the demand for specialized foot care products Growing awareness of diabetic foot complications is driving the market for creams and lotions Advancements in formulation technology are making these products more effective and appealing
The high cost of specialized diabetic foot care products can limit their adoption Lack of awareness in emerging markets is hindering market growth
There is a shift towards the use of organic and natural ingredients in diabetic foot care products The demand for online retail channels for these products is increasing
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The Cream & Lotion for Diabetic Foot Care Market is competitive, with key players like Bayer AG, GlaxoSmithKline, and Johnson & Johnson leading the market. Companies focus on product innovation, brand differentiation, and expanding distribution channels, including e-commerce. Smaller niche brands also compete by offering specialized and natural formulations.
January 2022: Medline Industries, L.P., has finalized the acquisition of United Medco, enhancing its portfolio in the diabetic foot care segment. This strategic move aims to expand Medline's product offerings and strengthen its position in the Cream & Lotion for Diabetic Foot Care Market, providing a broader range of solutions to meet the needs of patients managing diabetic foot conditions. (Source: https://newsroom.medline.com/releases/medline-industries-lp-completes-acquisition-of-united-medco/#:~:text=As%20part%20of%20the%20acquisition,all%20customers%20and%20team%20members. ) October 2023: Bayer is investing $250 million in a new cell therapy manufacturing facility in the U.S., aimed at advancing innovative treatments for diabetic foot care. This strategic move is expected to enhance the development of specialized creams and lotions, addressing the unique needs of diabetic patients and driving growth in the diabetic foot care market. (Source: https://www.bayer.com/media/en-us/bayer-invests-250-million-usd-in-new-cell-therapy-manufacturing-facility-in-the-us/) September 2022: B. Braun has acquired Clik-FIX® catheter securement devices from Starboard Medical, enhancing its portfolio in the diabetic foot care market. This acquisition allows B. Braun to expand its offerings in wound care and securement solutions, addressing the specific needs of diabetic foot care with innovative products designed to improve patient outcomes. (Source: https://www.bbraunusa.com/en/about-us/media/company-news/2022/b--braun-acquires-clik-fix--catheter-securement-devices-from-sta.html)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Bayer AG | ••• | ••• | ••• | ••• |
| GlaxoSmithKline plc | ••• | ••• | ••• | ••• |
| B. Braun Melsungen AG | ••• | ••• | ••• | ••• |
| Johnson & Johnson | ••• | ••• | ••• | ••• |
| Medline Industries | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
| Neoteric Cosmetics | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
| DJO Global | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Cream & Lotion for Diabetic Foot Care Market size was USD 780.8183369 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2024 to 2031.
The Cream & Lotion for Diabetic Foot Care Market focuses on products specifically formulated to prevent and treat foot complications in diabetic patients, such as dryness, cracks, ulcers, and infections. These products often contain moisturizing, anti-inflammatory, and antimicrobial ingredients to address the unique needs of diabetic foot care. Market growth is driven by the rising global prevalence of diabetes, increasing awareness of diabetic foot complications, and advances in product formulations. However, high costs and limited awareness in certain regions may constrain market expansion. Trends toward natural ingredients and the growing popularity of online retail channels also influence the market.
February 2024: GSK has finalized the acquisition of Aiolos Bio to strengthen its position in the diabetic foot care sector, enhancing its portfolio of creams and lotions. This strategic move aims to leverage Aiolos Bio’s innovative technologies and research capabilities to better address the needs of diabetic patients and expand GSK's market presence. (Source: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-acquisition-of-aiolos-bio/ )
Conclusion
★ Reviews
Rate this report
| Type | Antifungal Creams, Moisturizing Lotions, Antibacterial Creams, Others |
| End-User | Hospitals, Clinics, Home Care, Others |
| Distribution Channel | Online, Offline |
| List of Competitors | Bayer AG, GlaxoSmithKline plc, B. Braun Melsungen AG, Johnson & Johnson, Medline Industries, Inc., Neoteric Cosmetics, Inc., DJO Global, Inc. |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Cream & Lotion for Diabetic Foot Care Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Cream & Lotion for Diabetic Foot Care Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the cream & lotion for diabetic foot care market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.